ATE244244T1 - Iminochlorinasparaginsaeure-derivate - Google Patents

Iminochlorinasparaginsaeure-derivate

Info

Publication number
ATE244244T1
ATE244244T1 AT97941282T AT97941282T ATE244244T1 AT E244244 T1 ATE244244 T1 AT E244244T1 AT 97941282 T AT97941282 T AT 97941282T AT 97941282 T AT97941282 T AT 97941282T AT E244244 T1 ATE244244 T1 AT E244244T1
Authority
AT
Austria
Prior art keywords
aspartic acid
present
iminochlorinasparagic
acid derivatives
cancerous
Prior art date
Application number
AT97941282T
Other languages
English (en)
Inventor
Muneo Hikida
Masahiko Mori
Isao Sakata
Susumu Nakajima
Hiroyuki Takata
Original Assignee
Wyeth Lederle Japan Ltd
Photochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Lederle Japan Ltd, Photochemical Co Ltd filed Critical Wyeth Lederle Japan Ltd
Application granted granted Critical
Publication of ATE244244T1 publication Critical patent/ATE244244T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97941282T 1996-10-01 1997-09-30 Iminochlorinasparaginsaeure-derivate ATE244244T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27861196 1996-10-01
PCT/JP1997/003484 WO1998014453A1 (en) 1996-10-01 1997-09-30 Iminochlorinaspartic acid derivatives

Publications (1)

Publication Number Publication Date
ATE244244T1 true ATE244244T1 (de) 2003-07-15

Family

ID=17599698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97941282T ATE244244T1 (de) 1996-10-01 1997-09-30 Iminochlorinasparaginsaeure-derivate

Country Status (12)

Country Link
US (1) US6063777A (de)
EP (1) EP0945454B1 (de)
JP (1) JP3613599B2 (de)
KR (1) KR100463478B1 (de)
AT (1) ATE244244T1 (de)
AU (1) AU713059B2 (de)
CA (1) CA2268968C (de)
DE (1) DE69723298T2 (de)
DK (1) DK0945454T3 (de)
ES (1) ES2202640T3 (de)
PT (1) PT945454E (de)
WO (1) WO1998014453A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) * 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
EP1131100B1 (de) * 1999-01-15 2003-03-12 Light Sciences Corporation Therapeutische zusammensetzungen fur knochenstoffwechselstörungen oder knochenmetastasen enthaltend einen photosensitizer und ein bisphosphonat
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
KR100748908B1 (ko) * 1999-11-30 2007-08-13 가부시키가이샤 히까리케미카루겡뀨쇼 포르피린 화합물
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7753943B2 (en) * 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
US6800086B2 (en) 2001-02-06 2004-10-05 Qlt Inc. Reduced fluence rate PDT
EP1467760A2 (de) * 2002-01-23 2004-10-20 Light Sciences Corporation Systeme und verfahren zur photodynamischen therapie
JP4394334B2 (ja) * 2002-06-25 2010-01-06 浜松ホトニクス株式会社 脈管病に関する光物理化学的診断・治療薬
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
US20060282132A1 (en) * 2003-06-20 2006-12-14 Keio University Photodynamic therapy equipment, method for controlling photodynamic therapy equipment and method of photodynamic method
EP1648385B1 (de) 2003-07-31 2016-05-04 Gentlewaves Llc System und verfahren für die photodynamische behandlung von haut
WO2006085517A1 (ja) * 2005-02-08 2006-08-17 Photochemical Co., Ltd. クロリン類及びポルフィリン類のｐｄｔ用軟膏製剤及び坐剤
JP2006306743A (ja) * 2005-04-26 2006-11-09 Hamamatsu Photonics Kk 体液処理方法
JP5179245B2 (ja) * 2008-04-30 2013-04-10 功 阪田 皮膚疾患治療剤
JP7623666B2 (ja) 2020-04-16 2025-01-29 再生ファーマ株式会社 超音波増感剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS625986A (ja) * 1985-04-30 1987-01-12 Nippon Petrochem Co Ltd 新規なテトラピロ−ル化合物
JP3191223B2 (ja) * 1991-10-04 2001-07-23 株式会社光ケミカル研究所 ポルフィリン誘導体とその用途
JP3450399B2 (ja) * 1993-12-28 2003-09-22 大鵬薬品工業株式会社 血管新生阻害剤
JP3718887B2 (ja) * 1995-10-30 2005-11-24 株式会社光ケミカル研究所 ポルフィリン誘導体とその用途
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer

Also Published As

Publication number Publication date
AU713059B2 (en) 1999-11-25
AU4322997A (en) 1998-04-24
WO1998014453A1 (en) 1998-04-09
EP0945454A1 (de) 1999-09-29
PT945454E (pt) 2003-11-28
DK0945454T3 (da) 2003-10-27
KR100463478B1 (ko) 2004-12-29
EP0945454B1 (de) 2003-07-02
KR20000048843A (ko) 2000-07-25
US6063777A (en) 2000-05-16
JP3613599B2 (ja) 2005-01-26
CA2268968C (en) 2006-10-10
ES2202640T3 (es) 2004-04-01
EP0945454A4 (de) 1999-11-24
DE69723298T2 (de) 2004-02-05
CA2268968A1 (en) 1998-04-09
DE69723298D1 (de) 2003-08-07

Similar Documents

Publication Publication Date Title
DE69723298D1 (de) Iminochlorinasparaginsaeure-derivate
ATE252529T1 (de) Colchinolderivate als gefässschädigende mittel
NO943524D0 (no) Fremgangsmåte for behandling av tumor
PT1104760E (pt) Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
CA2335514A1 (en) Alkyl ether analogs of chlorins having an n-substituted imide ring
HK132493A (en) Porphyrins and cancer treatment
ATE252576T1 (de) Heteroarylphenylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel
DK1204650T3 (da) Substituerede 2-arylbenzazol-forbindelser og anvendelse deraf som antitumormidler
IT1137640B (it) Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
ATE359786T1 (de) Camptothecin derivate
BR9916096A (pt) Derivados de bacterioclorofila substituìdos compaládio e utilização dos mesmos
PT99134A (pt) Processo para a preparacao de derivados da piperazina
LU90073I2 (fr) Aceclofenac et ses sels et dérivés pharmaceutiquement acceptables (Air-tal)
AR240926A2 (es) "procedimiento para la preparacion de 8-isopropil-6-dimetilamino metil-7-hidroxi-4-metil-cumarina".
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
AU773261B2 (en) Porphyrin compound
SE7811455L (sv) 2-imino-imidazolidin-derivat
DE60031699D1 (de) Hydroxyacetamidobenzolsulfonamidderivate
US20040022734A1 (en) Dihydroporphyrin derivatives and their uses
NO20052360L (no) Forbedrede formuleringer inneholdende substituerte imidazolderivater
TR199801398T2 (xx) Ast�m� tedavi edici maddeler
RU2217426C2 (ru) Цианиминохиноксалиновые производные, способ их получения (варианты), промежуточные соединения и фармацевтическая композиция
NO803862L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0945454

Country of ref document: EP

EEFA Change of the company name
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner